Those results, expected in 2026, will likely confirm and potentially extend the Phase 2 findings given the consistency of dose-response data
This, in turn, boosts metabolic rate and activates a gene known as sirtuin-1 (SIRT1), also referred to as the "longevity gene." SIRT1 is involved in reducing the risk of various conditions such as diabetes, obesity, metabolic syndrome, atherosclerosis, cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer.
Lavie, H
En AdvaLife Nutraceuticals, nos enorgullecemos de nuestra amplia gama de suplementos dietticos, con ms de 150 formulaciones hechas exclusivamente de ingredientes de calidad premium